RMP-7 drug delivery system with carboplatin: ALKS began a European Phase I/II trial

Alkermes Inc. (ALKS), Cambridge, Mass. Product: RMP-7 drug delivery system with carboplatin Indication: Metastatic brain cancer Status: ALKS began a European Phase I/II trial with 300 ng/kg iv of RMP-...